Corbus Pharmaceuticals CEO to Present at Two Key Healthcare Conferences
Event summary
- Corbus Pharmaceuticals CEO Yuval Cohen to present at RBC Capital Markets Global Healthcare Conference on May 19, 2026.
- Cohen will also present at Jefferies Global Healthcare Conference on June 4, 2026.
- Both events include corporate overviews and one-on-one investor meetings.
- Corbus focuses on oncology and obesity therapies, with CRB-701 and CRB-913 in pipeline.
The big picture
Corbus Pharmaceuticals is actively engaging with investors amid a competitive landscape in biotech, particularly in oncology and obesity. The company's participation in high-profile conferences signals a push to highlight its pipeline and secure investor confidence. Success in these presentations could influence future funding and strategic partnerships.
What we're watching
- Pipeline Progress
- How updates on CRB-701 and CRB-913 will impact investor sentiment.
- Market Positioning
- Whether Corbus can differentiate itself in competitive oncology and obesity markets.
- Funding Strategy
- The pace at which Corbus advances toward potential partnerships or financing rounds.
Related topics